According to medical statistics, cardiovascular diseases are the most common death factor  in the world today. 

Thus, the heart was one of the first to be identified as one of the objects of regenerative cell therapy.

Here is the general procedure in treatment of heart failure

1. Examination of patients: general clinical tests, rest ECG, stress ECG (treadmill test), Echo, Holter monitor, SPECT of myocardium,  vascular Doppler ultrasound, chest X-ray studies, etc.
2. Bone marrow puncture 
3. Culturing of mesenchymal stem cells from autologous bone marrow (35-40 days) 
4. Intravenous transplantation of the prepared MSC culture 
5. Control examinations of patients, post-treatment follow-up (in 1, 3, 6, 12, 24 months)

Results of the Treatment of Patients with Ischemic Heart Disease Who Received
Systemic i/v MSC Transplantation

• Improvement of physical stress tolerance; 
• Frequency of angina attacks reduced; 
• Ejection fraction increased by 13-15%; 
• Enhancement of the myocardium perfusion.

Order a free consultation

After receiving your information our medical expert will examine it and give an answer about the possibility and feasibility of using cell therapy particularly in your case.